Figures & data
Table 1 Demographic information of the COPD patients (n=90)
Table 2 Risk factors related to the COPD patients and their comparison between the two groups
Table 3 The average level of MDA in the supplement and control groups
Table 4 The average serum levels of MMP2 and MMP9 in the supplement and placebo groups